Wednesday, August 3, 2022-
WOONSOCKET, Rhode Island — CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2022.
Key financial data
Second quarter highlights
- Total revenues increased to $80.6 billion, up 11.0% compared to prior year
- GAAP diluted EPS of $2.23 and Adjusted EPS of $2.40
Year-to-date highlights
- Total revenues increased to $157.5 billion, up 11.1% compared to prior year
- GAAP diluted EPS of $3.97 and Adjusted EPS of $4.62
- Generated cash flow from operations of $9.0 billion
- Repaid $1.5 billion of long-term debt
2022 Full-year guidance
- Raised GAAP diluted EPS guidance range to $7.23 to $7.43 from $6.93 to $7.13
- Raised Adjusted EPS guidance range to $8.40 to $8.60 from $8.20 to $8.40
- Raised cash flow from operations guidance range to $12.5 billion to $13.5 billion from $12.0 billion to $13.0 billion
CEO commentary
“Despite a challenging economic environment, our differentiated business model helped drive strong results this quarter, with significant revenue growth across all of our business segments. The continued success of our foundational businesses accelerated our strategy to expand access to health services and help consumers navigate to the best site of care. We remain a trusted community health destination for millions of individuals with health products and services that engage customers in all aspects of their health wherever and whenever they need it.”
— Karen S. Lynch, CVS Health President and CEO
